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INTRODUCTION
Since Guilleminaut et al. (1) proposed diagnostic
criteria for sleep apnea syndrome in 1976, this dis-
ease has been extensively studied. Patients with sleep
apnea syndrome (SAS) are more likely to develop
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cardiovascular disorders such as hypertension,
ischemic heart disease, and cerebrovascular disor-
ders due to changes in respiratory physiology in-
cluding nocturnal hypoxiemia and a decrease in
intrathoracic pressure (2-7). SAS is also likely to
exert adverse effects on hemodynamics in patients
with various cardiovascular disorders (8, 9).
Obstructive sleep apnea syndrome (OSAS) was
recently reported to also be a new complication of
liver cirrhosis with ascites (10), but there few re-
ports have appeared on a detailed evaluation of the
relationship between the stage of liver cirrhosis and
the frequency of sleep apnea or hypopnea. In the
present study, the relationship between the sever-
ity of liver cirrhosis and the occurrence of sleep
apnea was evaluated. We also evaluated changes in
autonomic nervous activities and QT dispersion in
electrocardiograms (ECG) in cirrhosis patients with
sleep apnea to investigate the influence to circula-
tory system of sleep apnea in liver cirrhosis.
PATIENTS AND METHODS
1) Patients
Forty-eight patients with liver cirrhosis, who had
been admitted to the Tokushima University Hospital
between February and December, 2004 were studied.
The etiology of the cirrhosis was chronic HCV in-
fections in all patients. The diagnosis of liver cirrhosis
was made based on patient history, physical ex-
amination, biochemical blood tests, coagulation
function tests, upper gastrointestinal endoscopy,
abdominal ultrasonography, and a liverbiopsy. Patients
in whom esophageal varices were demonstrated
by upper gastrointestinal endoscopy, and in whom
a reduction in the size of the liver, irregularity of
the liver surface, and the presence of splenomegaly
and ascites were confirmed by abdominal ultra-
sonography, were selected as subjects. In addi-
tion, the LC group was classified into 3 types, based
on the Child classification (11), as Child A (LC-A
group: 16 patients ; 10 men, 6 women), Child B (LC-B
group : 16 patients ; 11 men, 5 women) and Child C
(LC-C group : 16 patients ; 12 men, 4 women).
No history of cardiopulmonary disease was evident
in the LC group. A standard 12-lead ECG, exercise
ECG test, chest X-ray, and echocardiogram revealed
no abnormalities. The criteria for exclusion were :
systolic blood pressure>140 mmHg, diastolic blood
pressure >90 mmHg, current or recent (within 1
month) use of antiarrhythmic drugs and/or β-
adrenergic blockers, recent gastrointestinal bleed-
ing, diabetes mellitus, neurological disease, atrial
flutter or fibrillation, sinus tachycardia, sinus brady-
cardia and tonsil swelling. In addition, patients re-
ceiving Fisher’s solution, which contains L -arginine,
were included, because nitric oxide (NO) is produced
from L-arginine (12). Written informed consent was
obtained from all patients prior to their participa-
tion.
2) All-night recording using a portable sleep polygraph
Respiratory data during sleep were collected using
a portable sleep polygraph (Fuji Respironics, Inc.,
Tokyo, Japan). Continuous records of the oronasal
airflow by the thermocouple method, tracheal sound
signals by the microphone method, thoracic respi-
ratory signals by the airbag method, and arterial oxy-
gen saturation by the percutaneous two-wavelength
pulse-wave method were obtained.
The resulting data were analyzed by software
for the measurement of sleep apnea (Fuji Respironics,
Inc. Tokyo, Japan) on a personal computer (Windows
XP). The apnea-hypopnea index (AHI), the percu-
taneous arterial oxygen saturation, nocturnal de-
saturation >3% below base line per 1 hour (desatu-
ration index) and the duration of apneic events were
determined. An arrest of airflow and a 50% or greater
decrease in mean airflow with a duration of 10 sec-
onds or longer during sleep were defined as apneic
and hypopneic episodes, respectively, and the AHI,
the number of apneic and hypopneic periods com-
bined per 1 hour of sleep, was calculated. The full-
polygraph is fundamentally indispensable for diagnosis
of sleep apnea. However, a portable sleep polygraph
was used as screening examination of sleep apnea in
the present study.
3) Spectral analysis of heart rate variabilities and
evaluation of QTc dispersion using Holter ECG
A Holter ECG was recorded simultaneously with
the collection of the polygraph sleep data (13). A
simultaneous 2-channel recording from leads CM5
and CM1 was performed using a digital Holter ECG
system. The Holter ECG data, recorded on elec-
tromagnetic chips, were analyzed with a Holter ECG
analyzer (DMW-9000H, Fukuda Denshi Corporation,
Tokyo, Japan), and the R-R interval data, stored on
a hard disk, were analyzed by time series data analysis
software (FukudaDenshi, Tokyo, Japan) on a personal
computer (Windows XP). Extra and missing beats
were excluded from analysis of the R-R intervals.
A spectral analysis of heart rate variabilities was
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performed using data for the R-R intervals of 512
beats, and low frequency power (LF power ; 0.04-
0.15 Hz), high frequency power (HF power ; 0.15-
0.40 Hz), the ratio of LF power to HF power (LF/
HF ratio), and very low frequency power (VLF power;
0.008-0.04 Hz) were calculated by analyzing spectra
of heart rate variabilities at 0 -0.5 Hz using the
Hanning window (13, 14). In addition, QTc was de-
termined using the Bazett equation, and QTc dis-
persion was calculated from the difference in QTc
between leads CM5 and CM1. In the present study,
parameters of autonomic nervous activity (VLF,
LF, HF, and LF/HF) and QTc interval in sleep
apnea were deduced in the period more than 20
times of AHI.
4) Statistical analysis
The values are expressed as the mean ±SD, and
statistical analysis was performed using StatView
5.0 (SAS Institute Inc., USA). Values were compared
between the two groups using the Student’s t-test,
analysis of variance (ANOVA) and the post hoc
comparison (paired) and p<0.05 was considered to
be significant.
RESULTS
1) Patient characteristics (Table 1)
No significant difference was observed in themean
age or bodymass index (BMI) among the three groups.
The total bilirubin level was significantly higher in
Group C than in Group A or B. Serum albumin levels
were significantly lower in Groups B and C than in
Group A. The volume of ascites was significantly
greater in Groups B and C than in Group A.
Hepatic encephalopathy was noted in 2 patients
of Group C, but the frequency of occurrence did not
differ significantly among the three groups. The
prothrombin time and Child-Pugh score increased
significantly with the progression of liver cirrhosis.
NH3 levels were significantly higher in Group C
than in Group A. Desaturation index was 5.5±1.4 in
Group A, 13.8±4.9 in Group B, and 18.7±13.2 in
Group C and was significantly higher in Groups B
and C than in Group A. There were no patients with
central sleep apnea.
2) Apnea-hypopnea index (AHI) in cirrhosis patients
Figure 1a shows the AHI values for each group. The
AHI was 5.5±1.4 in Group A, 14.1±4.7 in Group B,
and 19.3±13.2 in Group C and was significantly
higher in Groups B and C than in Group A.
The AHI of patients with episodes of central sleep
apnea was 0.1±0.1 in Group A, 1.0±0.5 in Group
B, and 1.9±2.6 inGroupC. These AHI values were low
in all three groups and did not fulfill the diagnostic
criteria of central sleep apnea syndrome. In patients
with episodes of obstructive sleep apnea, the AHI
was 5.3±1.4 in Group A, 12.9±4.5 in Group B, and
17.1±13.4 in Group C, significantly higher in Group
B than in Group A and in Group C than in Groups A
and B.
The AHI was correlated with the Child-Pugh score
(Figure 1b), and moreover significant correlation
was observed between the AHI and the volume of
ascites in the present study (Figure 1c).
3) QT dispersion in cirrhosis patients
Figure 2a shows changes in QT dispersion in a
patient from Group A with no episode of sleep apnea.
The QT dispersion was 8 msec while the patient was
awake and 6 msec while asleep, with no significant
prolongation during sleep. Figure 2b shows changes
in the QT dispersion for a patient from Group C with
obstructive sleep apnea (AHI＝23.2). The values of
QTc dispersion duringwakeful hours and during sleep
were 22 msec and 62 msec, respectively, being
prolonged during episodes of apnea.
Figure 3 compares the degree of increase in QTc
dispersion during sleep between patients with and
those without sleep apnea. The QTc dispersion was
significantly prolonged in patients with sleep apnea.
4) Changes in the heart rate variability in cirrhosis
patients
Figure 4 shows pulse trends and spectra of heart
Table 1. Patients characteristics
Child A
(n＝16)
Child B
(n＝16)
Child C
(n＝6)
Age (y.o.)
BMI
T-Bil (mg/dl)
Alb (mg/dl)
Ascites (point)
Encephalopathy
PT (sec)
Child-Pugh score
NH3 (µg/dl)
Desaturation index (times/hr)
AHI > 20 (cases)
Central sleep apnea (cases)
66.0±4.7
25.9±3.9
1.3±0.3
3.6±0.4
1.2±0.4
1.0±0.0
13.0±0.4
5.5±0.5
83.0±24.1
5.4±1.6
0
0
64.8±6.1
25.7±3.1
1.6±0.4＊
2.8±0.4＊
2.1±0.9＊
1.0±0.0
15.8±0.8＊
8.6±0.7＊
120.8±55.5＊
13.8±4.9＊
2
0
67.9±3.6
24.7±5.5
3.3±1.8＊†
2.5±0.3＊
2.5±0.7＊
1.1±0.3
18.0±1.4＊†
10.9±0.8＊†
146.3±70.3＊†
18.7±13.2＊†
6
0
BMI, body mass index ; T-Bil, total birilbin ; Alb, albumin ; PT,
prothrombin time ; NH3, ammonia ; Encephalopathy (grade 0 : 1
point, grade 1～2 : 2 point, grade 3～4 : 3 point) ;
Ascites (absent : 0 point, mild : 2 point, moderate～severe : 3 point)
＊p<0.05 vs Child A,†p<0.05 vs Child B
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rate variability during intervals (panel a) and episodes
(panel b) of sleep apnea. In the spectrum of heart rate
variability during the intervals of sleep apnea, LF was
63.8 msec2, HF was 63.8 msec2, LF/HF was 1.02,
and VLF was 112.0 msec2 ; in the spectrum during
episodes of sleep apnea, these values were 187.2
msec2, 447.3 msec2, 0.42, and 558.0 msec2, respec-
tively. TheHF power andVLF power increased during
episodes of sleep apnea.
Figure 5 shows the pulse trends and spectra of heart
rate variability in a patient with no sleep apnea. The
LF 34.1 wasmsec2, HFwas8.0msec2, LH/HFwas4.27,
and VLF was 67.8 msec2 ; an increase in LF/HF and
a decrease in HF were observed. In this patient, no
change in the values of the parameters for heart rate
variability as observed in Figure 4 was noted.
Figure 2．Changes in QT dispersion in a Group A patient with
no sleep apnea (panel a) and Group C patient with sleep apnea
(panel b).
Two vertical lines indicate the end of T waves in each ECG lead.
Figure 3．Comparison of the degree of increase in QTc dispersion
during sleep between patients with and without sleep apnea.
Figure 1．AHI values in each study group of liver cirrhosis
(panel a).
Correlation between Child-Pugh score and AHI value in all patients
(panel b).
Correlation between AHI value and volume of ascites (panel c).
AHI, apnea-hypopnea index.
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Table 2 shows the comparison with each pa-
rameters of heart rate variability during sleep
apnea or no sleep apnea in LC. The LF, HF, and
VLF during sleep apnea were significantly in-
creased more than during no sleep apnea (p<
0.01). On the other hand, LF/HF during sleep ap-
nea was significantly decreased more than during
no sleep apnea (p<0.01).
DISCUSSION
In the present study, sleep apnea was observed in
cirrhosis patients with moderate or severe ascites.
Moreover, the AHI tended to be higher with in-
creasing volume of ascites. Thus, a relationship
between ascites and obstruction of the upper res-
piratory tract during sleep appears to exist in cir-
rhosis patients.
Concerning the relationship between autonomic
nervous activities and QT dispersion during apneic
episodes in cirrhosis patients, increases in para-
sympathetic activities and QT dispersion were
observed, increasing the risks of bradycardiac ar-
rhythmia and ventricular arrhythmia. Along with the
report that the type C hepatitis virus is a cause of
myocardial damage (15, 16), these findings suggest
that sleep apnea in cirrhosis patients increases the
risk of fetal arrhythmia.
1) Relationship between liver cirrhosis and sleep apnea
Hepatic encephalopathy has long been reported to
cause sleep disorders. Symptoms of sleep disorders,
which include sleepiness during the daytime, reduced
attention, and frequent awakening during the night,
resemble those of SAS, but the relationship be-
tween cirrhosis and SAS has not been studied ex-
tensively. According to a study by Crespo et al. (10),
OSAS was observed in 2 patients with high Child-
Pugh scores among 24 cirrhosis patients with as-
cites, excluding those with hepatic encephalopa-
thy, but OSAS disappeared after the drainage of
ascites. They concluded that the mechanism of
OSAS in these patients was primarily mechanical
and that it was caused by a decrease in functional
residual volume and obstruction of the upper air-
way due to an extension of the abdominal girth
and elevation of the diaphragm.
In the present study, we expected an increase in
the frequency of central apnea in Group C, because
ammonia levels were increased, steroid metabo-
lism was disturbed, and aromatic amino acids in-
Figure 4．Pulse trends and spectra of heart rate variability
during intervals (panel a) and episodes (panel b) of sleep
apnea.
Figure 5．Pulse trends and spectra of heart rate variability for
a patient with no sleep apnea.
Table 2. Comparisonwith each parameters of heart rate variability
during sleep or no-apnea episode in LC
During
sleep apnea
During no
sleep apnea
p value
LC
without sleep
apnea
LF(msec2)
HF(msec2)
LF/HF
VLF(msec2)
―
―
―
―
57.2±20.6
24.5±11.3
2.96±1.78
255.7±153.9
LC
with sleep
apnea
LF(msec2)
HF(msec2)
LF/HF
VLF(msec2)
1010.8±1152
1613.3±1407
0.58±0.22
3895.7±2685.4
131.6±122.2
90.8±90.3
1.70±0.73
544.0±377.0
<0.01
<0.01
<0.01
<0.01
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crease with a decline in liver function in patients
with no or a small volume of ascites. However, cen-
tral apnea case was not observed, and obstructive
sleep apnea was predominant. However, patient’s
consciousness level was not evaluated because
electroencephalography was not performed in the
present study.
2) Mechanism of heart rate variability
Heart rate variability includes periodic changes
that have particular frequencies (17-22). Two major
peaks, i.e., low frequency power (LF, 0.04 - 0.15Hz) and
high frequency power (HF, 0.15 - 0.4 Hz) are observed
in the spectrum of heart rate variability at rest. The
HF power corresponds to respiratory sinus arrhyth-
mia, and its frequency is equal to the respiratory
frequency. The mechanisms of HF power are in-
terference of the cardiovascular center by the res-
piratory center in the brainstem and the input from
stretch receptors of the lungs to the cardiovascu-
lar center. By these mechanisms, the vagus output to
the heart decreases during expiration and increases
during inspiration. Concerning the mechanism of
LF power, the systolic blood pressure shows periodic
changes occurring in approximately 10 - second cycles,
called Mayer waves (23). LF power occurs as changes
in blood pressure due to these Mayer waves are
reflected in the pulse via pressure receptor reflex.
The LF power is considered to be an index of sym-
pathetic activities, and HF power to reflect para-
sympathetic activities. The LF/HF ratio, which in-
creases when standing upright, during exercise, and
under psychological stress, is considered to be an
index of sympathetic activities.
In the present study, a decrease in HF power,
probably reflecting hyperdynamic circulation in
cirrhosis patients, and an increase in LF/HF were
observed during intervals of sleep apnea, agree-
ment with the report of Iga et al. (24). They studied
sympathetic activities in cirrhosis patients by
measuring noradrenaline (NA) levels and 123I-
metaiodobenzylguanidine (MIBG) myocardial scin-
tigraphy. As a result, the NA level and washout rate
on myocardial scintigraphy were significantly in-
creased in Child A and Child B groups, but were
increased further in the Child C group, suggesting that
sympathetic activities are enhanced with the pro-
gression of liver cirrhosis. However, increases in HF
power and VLF power were also observed during
episodes of seep apnea in cirrhosis patients in the
present study. It is suggested that HF power changes
with depth of respiration during sleep apnea, and
VLF power reflects rhythmic oscillation of peri-
odic bradycardia induced sleep apnea.
3) QT dispersion and autonomic nerves
QT dispersion is usually token to indicate the
difference between the maximum QT interval and
minimum QT interval in standard 12-lead ECG.
Ashida et al. (25) compared QT dispersions obtained
by CM5 andCM1 leadswith those obtained by standard
12-lead ECG, and reported that the Holter ECG
obtained with appropriate leads is sufficient for
clinically evaluating serial changes in QT dispersion
during daily activities or before and after the oc-
currence of arrhythmia. Therefore, we evaluated the
QT dispersion obtained by a Holter ECG instead
of a 12-lead ECG because of the difficulty in the serial
recording of 12-lead ECG during nighttime sleep.
In the present study, for convenience, the difference
between lead CM5 and lead CM1 of the Holter ECG
was regarded as QT dispersion. According to the
literature, the normal range of QT dispersion is 50
msec or less (26), and 50 -100 msec is regarded as a
caution range, and 100msec or higher as a risk range,
in predicting the occurrence of ventricular arrhyth-
mia.
The QT interval shows temporal and spatial vari-
ations, and is susceptible to the effects of autonomic
nervous activities. Humoral factors and nervous factors
must be considered separately, but because of the
uneven distribution of sympathetic nerve terminals
in the myocardium, sympathetic stimulation causes
variations in the shortening of the refractory period
and promotes the occurrence of reentry arrhythmia.
Autonomic disorders are considered to widen the
variation of QT and, thus, to possibly induce arrhythmia
(27). In the present study, increase in QT disper-
sion were noted during episodes of sleep apnea in
liver cirrhotic patients, and this increased sympa-
thetic nervous activity and QT dispersionmay further
induce cardiac events.
4) Occurrence of sleep apnea and arrhythmia in liver
cirrhosis
According to the results of Guilleminault et al. (28)
who studied 400 patients with arrhythmia compli-
cated by SAS, arrhythmia was concurrent with sleep
apnea in 48% of the patients, and bradycardiac ar-
rhythmia, such as sinus bradycardia, at less than
30 bpm (7%), sinus arrest of 2.5 seconds or longer
duration, and second degree A-V block was ob-
served in about half the patients. Hypoxemia due
to apnea not only directly causes a decrease in PaO2
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but also stimulates chemoreceptors, affects the central
nervous system, and increases blood catecholamine
levels, but, despite the complexity of factors, the lack
of stretch reflex of the lungs and stimulation of
chemoreceptors are speculated to enhance para-
sympathetic activities and cause bradycardia.
Shepard (29) also reported that the frequency of
appearance of ventricular arrhythmia increases when
SaO2 decreases to below 60%. A study of the effects
of nocturnal arrhythmia in SAS patients with no
underlying disease reported that lethal arrhythmia
was absent or very infrequent but that the number
of ventricular extrasystoles was significantly in-
creased in the SAS group compared to the control
group. The number of ventricular extrasystoles de-
creased significantly after successful treatment.
These findings suggest that hypoxia and sympa-
thetic hyperactivity are involved in the occurrence
of ventricular extrasystoles during sleep.
Sympathetic nervous activities are enhanced as
cirrhosis progresses (27). Therefore, in the present
studywe examined the issue of whether the frequency
of sleep apnea or hypopnea increases with pro-
gression of cirrhosis. As cirrhosis progresses with
sleep apnea, the balance of autonomic nervous ac-
tivities appears to shift from sympathetic dominance
to parasympathetic dominance, and, with an asso-
ciated increase in QT dispersion, the risks of both
ventricular arrhythmia and bradycardiac arrhythmia
are thought to increase. Although no severe arrhyth-
mia was observed in the subjects of this study, lethal
arrhythmia may occur in cirrhosis patients with
sleep apnea if they also have cardiac complica-
tions.
In conclusion, with the progression of liver cirrhosis,
sleep apnea appeared, and changes in autonomic
nervous activities were observed. Moreover, ab-
normal autonomic nervous activities and an increase
in QT dispersion were noted during episodes of sleep
apnea, suggesting an increased risk of ventricular
arrhythmia.
STUDY LIMITATIONS
It is suggested that QTc dispersion varies with
sleep stage depending on the change of autonomic
nervous activity. However, patient’s sleep stage was
not identified in the present study because the
electroencephalography was not performed. In
future study, the relation between sleep stage, QT
dispersion, and autonomic nervous activity would
become clear using full-polygraphy.
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